Abstract

We recently discovered that the antidepressant sertraline is an effective inhibitor of hippocampus presynaptic Na+ channel permeability in vitro and of tonic-clonic seizures in animals in vivo. Several studies indicate that the pro-inflammatory cytokines in the central nervous system are increased in epilepsy and depression. On the other hand inhibition of Na+ channels has been shown to decrease pro-inflammatory cytokines in microglia. Therefore, the possibility that sertraline could overcome the rise in pro-inflammatory cytokine expression induced by seizures has been investigated. For this purpose, IL-1β and TNF-α mRNA expression was determined by RT-PCR in the hippocampus of rats administered once, or for seven consecutive days with sertraline at a low dose (0.75 mg/kg). The effect of sertraline at doses within the range of 0.75 to 25 mg/kg on the increase in IL-1β and TNF-α mRNA expression accompanying generalized tonic-clonic seizures, and increase in the pro-inflammatory cytokines expression induced by lipopolysaccharide was also investigated. We found that under basal conditions, a single 0.75 mg/kg sertraline dose decreased IL-1β mRNA expression, and also TNF-α expression after repeated doses. The increase in IL-1β and TNF-α expression induced by the convulsive agents and by the inoculation of lipopolysaccharide in the hippocampus was markedly reduced by sertraline also. Present results indicate that a reduction of brain inflammatory processes may contribute to the anti-seizure sertraline action, and that sertraline can be safely and successfully used at low doses to treat depression in epileptic patients.

Highlights

  • Psychiatric disorders, and depression, are known as frequent co-morbidities in patients with epilepsy [1,2,3,4,5,6,7]

  • Group 5 (G5), was administered once with saline followed by 4AP; Group 6 (G6), was administered once with 0.75 mg/kg sertraline followed by 4-AP, Group 7 (G7) with 0.75 mg/kg sertraline daily for one week, followed by 4-AP, Group 8 (G8) with saline followed by PTZ; Group 9 (G9) with sertraline at a dose of 2.5 mg/kg followed by PTZ, and Group 10 (G10) with 25 mg/kg sertraline followed by PTZ

  • We show that in the control groups injected with the vehicle once (G1), or 7 times (G3), the baseline mRNA expression of both cytokines is very similar

Read more

Summary

Introduction

Psychiatric disorders, and depression, are known as frequent co-morbidities in patients with epilepsy [1,2,3,4,5,6,7]. Voltage sensitive Na+ channels are involved in exacerbating neuronal excitability during seizures. Among the most effective of all anti-epileptic drugs are those capable of decreasing voltage sensitive Na+ channel permeability. In hippocampal isolated nerve endings, sertraline, a drug broadly prescribed for the treatment of depression [21], in addition to its action on the 5-HT transporter, resulted in a potent and effective inhibitor of voltage sensitive Na+ channel permeability [22]. In mixed glial cell cultures the Na+ channel blocker, tetrodotoxin, as well as the classic anti-epileptic drug, phenytoin, whose mechanism of action involves inhibition of Na+ channels, reduced the secretion of the pro-inflammatory cytokines interleukin-1beta (IL-1b) and TNF-a induced by lipopolysaccharide [24]. We measured the effect of sertraline on the increase in those pro-inflammatory cytokines induced by seizures

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call